Article Information
History
- June 17, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- William Fischer, MD1,
- Joseph J. Eron Jr, MD2,
- Wayne Holman, MD3,
- Myron S. Cohen, MD4,
- Lei Fang, MS5,
- Laura J. Szewczyk, BS3,
- Timothy P Sheahan, PhD6,
- Ralph Baric6,
- Katie R. Mollan, MS7,
- Cameron R. Wolfe, MBBS MPH8,
- Elizabeth R. Duke, MD MA9,
- Masoud M. Azizad, MD10,
- Katyna Borroto-Esoda, MS11,
- David A. Wohl, MD1,
- Amy James Loftis, BSc4,
- Paul Alabanza, BSc12,
- Felicia Lipansky3 and
- Wendy P. Painter, MD MPH3,*
- 1Institute for Global Health and Infectious Disease, Division of Pulmonary Diseases and Critical Care Medicine, The University of North Carolina and Chapel Hill, Chapel Hill, NC, USA
- 2Department of Medicine, Division of Infectious Diseases, The University of North Carolina and Chapel Hill, Chapel Hill, NC, USA
- 3Ridgeback Biotherapeutics LP, Miami, FL, USA
- 4Institute for Global Health and Infectious Disease, The University of North Carolina and Chapel Hill, Chapel Hill, NC, USA
- 5Pharstat Inc., Raleigh, NC, USA
- 6Department of Epidemiology, The University of North Carolina and Chapel Hill, Chapel Hill, NC, USA
- 7Gillings School of Global Public Health, School of Medicine, The University of North Carolina and Chapel Hill, Chapel Hill, NC, USA
- 8Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA
- 9Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA
- 10Valley Clinical Trials, Inc., Northridge, CA, USA
- 11KBE Consulting, Raleigh, NC, USA
- 12Lineberger Comprehensive Cancer Center, The University of North Carolina and Chapel Hill, Chapel Hill, NC, USA
- ↵*Corresponding author: Wendy P. Painter, MD, MPH, Ridgeback Biotherapeutics, Miami, FL, USA. painter{at}ridgebackbio.com
Posted June 17, 2021.
